ABT-107, CAS 855291-54-2

Product Description: ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions[1][2].

Applications: Neuroscience-Neurodegeneration

Formula: C19H20N4O

References: [1]R Scott Bitner, et al. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. J Pharmacol Exp Ther. 2010 Sep 1;334(3):875-86./[2]Tanuja Bordia, et al. The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions. Exp Neurol. 2015 Jan;263:277-84.

CAS Number: 855291-54-2

Molecular Weight: 320.39

Compound Purity: 99.73

Research Area: Neurological Disease

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: nAChR

• Artikelnummer: MEXHY-108038-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-108038-10.1
• Verpackungseinheit: 10 mM/1 ml
• Mengeneinheit: STK